3 Reasons Organigram Hit a Home Run With Its Q1 Results
What a difference one quarter can make. Just three months ago, OrganiGram Holdings (NASDAQ: OGI) thoroughly disappointed investors with its fiscal 2019 fourth-quarter results. In November, the Canadian cannabis producer reported lower-than-expected revenue and a hefty net loss.
But Organigram provided much better news for investors with its fiscal 2020 first-quarter results announced after the market closed on Tuesday. Shares soared in after-hours trading, with the company delivering better-than-expected numbers. Here are three reasons Organigram hit a home run with its Q1 results.
Image source: Getty Images.
Source Fool.com
